Federal officials had warned that the new product from the online provider of weight loss drugs might be illegal.

Telehealth company Hims & Hers dropped its plan to offer a knockoff version of the weight-loss pill Wegovy on Saturday — two days after it announced the new drug. The decision came one day after ...

Companies looking to sell weight-loss drugs directly to consumers, including Novo Nordisk's Wegovy, will shell out millions ...

TrumpRx is aimed at helping patients use their own money to buy medicines. But researchers who study drug pricing warned that ...

The FDA said on Friday it plans to restrict GLP-1 ingredients used in non-approved compounded drugs from companies like Hims & Hers.

At a starting cost of just $49 per month, the new pills are the cheapest GLP-1 option yet. But experts say compounded drugs like this one pose risks.

US stocks rebounded on Friday from a weeklong tech bruising as Wall Street reassessed worries about the impact of AI disruption and the risks of hefty Big Tech spending. The Dow Jones Industrial ...

Novo Nordisk vowed to take legal action against telehealth company Hims & Hers for selling a knockoff of its weight loss pill ...

Hims & Hers' gambit to sell a $49 compounded version of Novo Nordisk's Wegovy pill is rattling obesity shares, sparking ...

Hims & Hers' gambit to sell a $49 compounded version of Novo Nordisk's Wegovy pill is rattling obesity shares, sparking ...

The announcement from Hims is the latest example of the company's efforts to capitalize on obesity drugs like Wegovy, which ...

This is the worst price drawdown in Novo Nordisk's history, going back to 1990. Despite this, the stock has produced a ...